Details

Autor(en) / Beteiligte

• Riske, Brenda
• Shearer, Rick
• Baker, Judith R.

Titel

Patient satisfaction with US Hemophilia Treatment Center Care, Teams and Services: The First National Survey

Ist Teil von

• Haemophilia : the official journal of the World Federation of Hemophilia, 2020-11, Vol.26 (6), p.991-998

Ort / Verlag

England: Wiley Subscription Services, Inc

Erscheinungsjahr

2020

Quelle

Wiley-Blackwell Journals

Beschreibungen/Notizen

• Introduction Patient satisfaction with health care is a key quality metric, associated with adherence and better outcomes. However, satisfaction with US Hemophilia Treatment Centers (HTC) is unknown. Aim To assess patient satisfaction with US Hemophilia Treatment Centers. Methods A nationally uniform survey was conducted using the US HTC Network's regional infrastructure. Satisfaction with multidisciplinary team members, services and care processes was assessed. The anonymous survey, in English and Spanish, was disseminated to 28 289 households. Data were aggregated using 4 standard US Census regions. Results 5006 individuals (17.7%) who obtained care from 133 (96.4%) of 138 HTCs in 2014 responded. Satisfaction with overall HTC care at ‘always’ or ‘usually’ (A/U) levels ranged 94.2%‐97.9% regardless of patient gender, age, race, ethnicity, language, diagnosis, severity, region or frequency of HTC contact. A/U satisfaction with HTC haematologist, nurse, social worker or physical therapist, individually, ranged 95.1%‐97.3% nationally. A/U satisfaction with three HTC services was 89.5%‐96.9% and 94.9%‐98.0% for five HTC care processes nationally. Regional satisfaction at A/U levels was at least 87.0%. Nationally, 26.4% and 21.2% rated insurance and language, respectively, as A/U problems in getting needed HTC services. Conclusion Patient satisfaction with US Hemophilia Treatment Center care, multi‐disciplinary teams, services and processes was consistently high, documenting the value patients place on HTCs. The successful survey administration demonstrates the capability of the Network's regional infrastructure. Access to the US HTC Network is particularly critical to ongoing health in this new era of novel and gene therapies.